Synthesis and in vivo evaluation of novel radiotracers for the in vivo imaging of the norepinephrine transporter

Nuclear Medicine and Biology

Volumn 30, Issue 2, 2003, Pages 85-92

  Wilson, Alan A ^a   Johnson, David Patrick ^b   Mozley, David ^b   Hussey, Doug ^a   Ginovart, Nathalie ^a   Nobrega, Jose ^a   Garcia, Armando ^a   Meyer, Jeffery ^a   Houle, Sylvain ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Autoradiography; Carbon 11; Norepinephrine transporter; PET; Rat; Reboxetine

Indexed keywords

2 [(2 METHOXYPHENOXY)PHENYLMETHYL]MORPHOLINE; DESIPRAMINE; DOPAMINE; LIGAND; MORPHOLINE DERIVATIVE; NORADRENALIN; NORADRENALIN TRANSPORTER; NORADRENALIN UPTAKE INHIBITOR; REBOXETINE; SEROTONIN; TRACER; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BRAIN; BRAIN SLICE; CONTROLLED STUDY; CORPUS STRIATUM; ENANTIOMER; EVALUATION; HYPOTHALAMUS; IN VIVO STUDY; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; SYNTHESIS;

EID: 0242340372     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(02)00420-1     Document Type: Article

References (30)

1. 3H]nisoxetine autoradiography. Brain Res. 582:1992;208-214.
2. Belej T., Manji D., Sioutis S., Barros H.M., Nobrega J.N. Changes in serotonin and norepinephrine uptake sites after chronic cocaine pre- vs . post-withdrawal effects, Brain Res. 736:1996;287-296.
3. 3H]Desmethylimipramine Binding Sites in Rat Brain by Quantitative Autoradiography. J. Neurosci. 3:1983;1069-1076.
4. R.D. Blakely, L.J. Defelice, H.C. Hartzell, Molecular physiology of norepinephrine and serotonin transporters, J. Exp. Biol. (1994).
5. Brunswick D.J., Benmansour S., Tejani-Butt S.M., Hauptmann M. Effects of high-dose methamphetamine on monoamine uptake sites in rat brain measured by quantitative autoradiography. Synapse. 11:1992;287-293.
6. 3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments . Neuropharmacology. 35:1996;63-70.
7. Chumpradit S., Kung M.P., Panyachotipunm V., Prapansiri C., Foulon B.P., Brooks S.A., Szabo S., Tejani-Butt A., Frazer H.F., Kung. Iodinated tomoxetine derivatives as selective ligands for serotonin and norepinephrine uptake sites. J. Med. Chem. 35:1992;4492-4497.
8. 11C]methyl iodide. Appl. Radiat. Isot. Int. J. Appl. Instrum. Part A. 38:1987;601-603.
9. Domino E.F. Monoamine oxidase substrates and substrate affinity. Schizophr. Bull. 6:1980;292-297.
10. 11C]Nisoxetine, a Norepinephrine Uptake Inhibitor. Nucl. Med. Biol. 16:1989;771-774.
11. Hilton J., Yokoi F., Dannals R.F., Ravert H.T., Szabo Z., Wong D.F. Column-switching HPLC for the analysis of plasma in PET imaging studies. Nucl. Med. Biol. 27:2000;627-630.
12. Horn A.S., Coyle J.T., Snyder S.H. Catecholamine uptake by synaptosomes from rat brain structure activity relationships of drugs with differential effects on dopamine and norepinephrine . Mol. Pharmacol. 7:1971;66-80.
13. 11C]-doxepin. J. Labelled. Compd. Radiopharm. 45:2002;271-280.
14. Langer O., Halldin C. PET and SPET tracers for mapping the cardiac nervous system. Eur. J. Nucl. Med. 29:2002;416-434.
15. Melloni P., Carniel G., Della Torre A., Bonsignori A., Buonamici M., Pozzi O., Ricciardi O., Rossi A.C. Potential antidepressant agents, α-Aryloxy-benzyl derivatives of ethanolamine and morpholine. Eur. J. Med. Chem. 19:1984;235-242.
16. Melloni P., Della Torre A., Lazzari E., Mazzini G., Meroni M. Con|figurational Studies on 2-[α-(2-ethoxyphenoxy)benzyl]morpholine FCE 20124. Tetrahedron. 41:1985;1393-1399.
17. Pacholczyk T., Blakely R.D., Amara S.G. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature. 350:1991;350-354.
18. 3H]desipramine to rat brain a presynaptic marker for noradrenergic uptake sites . J. Neurochem. 38:1982;889-895.
19. Strazielle C., Lalonde R., Hebert C., Reader T.A. Regional brain distribution of noradrenaline uptake sites, and of alpha1-alpha2- and beta-adrenergic receptors in PCD mutant mice a quantitative autoradiographic study . Neuroscience. 94:1999;287-304.
20. 3H]nisoxetine a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding . J. Pharmacol. Exp. Ther. 260:1992;427-436.
21. van der Zee P., Hespe W. Interaction Between Substituted 1-[2-(Diphenylmethoxy)ethyl] Piperazines and Dopamine Receptors. Neuropharmacol. 24:1985;1171-1174.
22. 11C-labeled desipramine and its metabolite 2- hydroxydesipramine potential radiotracers for PET studies of the norepinephrine transporter . Nucl. Med. Biol. 24:1997;707-711.
23. 3]-carbomethoxy-3β-aryltropanes radiotracers for the dopamine transporter . J. Labelled. Compd. Radiopharm. 34:1994;759-765.
24. 18F]-labelled cocaine analogues as potential dopamine transporter ligands for positron emission tomography. Nucl. Med. Biol. 23:1996;141-146.
25. 11C]-iodomethane a remarkably simple captive solvent method . Nucl. Med. Biol. 27:2000;529-532.
26. 11]C-labeled 2-(phenylthio)araalkylamines . J. Med. Chem. 43:2000;3103-3110.
27. Wilson A.A., Jin L., Garcia A., DaSilva J.N., Houle S. An admonition when measuring the lipophilicity of radiotracers using counting techniques. Appl. Rad. Isot. 54:2001;203-208.
28. Wong E.H., Sonders M.S., Amara S.G., Tinholt P.M., Piercey M.F., Hoffmann W.P., Hyslop D.K., Franklin S., Porsolt R.D., Bonsignori A., Carfagna N., McArthur R.A. Reboxetine a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor . Biol. Psychiatry. 47:2000;818-829.
29. E.H.F. Wong, S. Ahmed, R.C. Marshall, R. McArthur, D.P. Taylor, L. Birgerson, P. Cetera, Highly selective norepinephrine reuptake inhibitors and methods of using the same patent, IP # WO 01/01973 A2, (2001).
30. Zafar H.M., Pare W.P., Tejani-Butt S.M. Effect of acute or repeated stress on behavior and brain norepinephrine system in Wistar-Kyoto (WKY) rats. Brain. Res. Bull. 44:1997;289-295.